Literature DB >> 17479916

Misdiagnosing melioidosis.

Andrew J Brent, Philippa C Matthews, David A Dance, Tyrone L Pitt, Rupert Handy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17479916      PMCID: PMC2725863          DOI: 10.3201/eid1302.061290

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: Melioidosis is endemic in southern and Southeast Asia and northern Australia. Although relatively few indigenous cases are recognized in the Indian subcontinent, a substantial proportion of cases imported into the United Kingdom originate there, probably reflecting patterns of immigration and travel, and underdiagnosis within the Indian subcontinent (–). A 33-year-old woman spent 3 months in India. Shortly after arriving there, fever, myalgia, rigors, pharyngitis, and tender cervical lymphadenopathy developed. After she received antimicrobial agents, her symptoms initially improved, but in September 2005, 1 week after returning to the United Kingdom, she visited her general practitioner with recurrent fever and increasingly painful cervical lymphadenopathy. She was given a course of oral co-amoxiclav 625 mg 3× daily. However, the following week she visited the emergency department of her local hospital with left-sided suppurative cervical lymphadenitis. Pus aspirated from the lymph node grew an aminoglycoside-resistant “pseudomonad” identified as Pseudomonas fluorescens (API20NE profile 1056554), assumed to be a contaminant. She was discharged home to complete a further 10-day course of co-amoxiclav. One month later, the patient again went to the emergency department, this time with a submental abscess. An otolaryngology consultation was sought, and the abscess was incised and drained. Although tuberculosis was suspected, no acid-fast bacilli were identified, and cultures were negative for mycobacteria; histologic examination showed noncaseating granulomata. Culture of fluid from the submental collection again yielded an aminoglycoside-resistant pseudomonad, however. At this point misidentification was suspected, and the isolate, which had a characteristic colony form on Ashdown’s Medium, microscopic appearance (Figure panel A), API20NE profile (1556574), and fatty acid profile, was identified as Burkholderia pseudomallei, the etiologic agent of melioidosis. The patient had no relevant past medical history. Before immigrating to the United Kingdom 3 years earlier, she had lived in Tanjore, a rice-farming area of Tamil Nadu. She had stayed with family there during her recent trip, which coincided with the monsoon season, but she denied rural travel, fresh water contact, or skin abrasions. On examination, she was obese with acanthosis nigricans and tender cervical lymphadenopathy. Blood tests showed a mild microcytosis, low ferritin level, and erythrocyte sedimentation rate 40 mm/h; serum biochemistry and levels of C-reactive protein, fasting glucose, and hemoglobin by electrophoresis were normal. Two blood cultures were negative. Results of chest and abdominal imaging were normal. The patient was treated with intravenous ceftazidime for 10 days and oral co-trimoxazole for 4 months. She remains well. B. pseudomallei serologic tests, performed subsequently, showed negative results by ELISA against the standard laboratory strain (204). However, when the assay was repeated using the patient’s own isolate, the result was positive (immunoglobulin G titer 4,000). Comparison of lipopolysaccharide (LPS) antigens from the 2 strains by sodium dodecyl sulfatepolyacrylamide gel electrophoresis and immunoblotting showed that they differed in O-repeating units (Figure panel B). B. pseudomallei is an aerobic, gram-negative, environmental saprophyte ubiquitous in soil and surface water (e.g., paddy fields) in disease-endemic areas. Acquisition may occur through skin abrasions, aspiration of fresh water, inhalation, and possibly ingestion and may occasionally occur in the laboratory. An association between severe respiratory melioidosis and heavy monsoonal rains suggests that inhalation has previously been underrecognized as a route of infection (); this is the likely mode in this case. Many infections are initially subclinical but may result in latency and delayed manifestations, even after several decades. Clinical signs and symptoms include septicemia, cavitating pneumonia, bone and soft tissue infections, disseminated abscesses, mycotic aneurysms, lymphadenitis, and childhood parotitis. Most patients have an underlying predisposition to infection, especially diabetes, renal disease, alcoholism, and thalassemia, but in the largest Indian case series 50% patients had no traditional risk factors, as with our patient (). B. pseudomallei is a category B potential bioterrorism agent. Limited awareness of the disease, confusion with other conditions such as tuberculosis, and laboratory constraints all probably contribute to underdiagnosis of melioidosis in many areas (). However, accurate diagnosis is important because septicemic melioidosis may be rapidly fatal, B. pseudomallei is intrinsically resistant to many antimicrobial agents, and prolonged treatment is usually required to minimize relapse. Diagnosis is usually by culture from sterile sites. Laboratory misidentification is not uncommon and occurred in this case because the diagnosis was not considered. Isolation of aminoglycoside-resistant pseudomonads in patients from disease-endemic areas should always prompt consideration of melioidosis and accurate identification. PCR is an emerging diagnostic tool not yet extensively validated (). The role of serology in diagnosis is limited by high background seropositivity rates in disease-endemic areas. No standardized serologic test is internationally agreed upon. This case illustrates another potential pitfall in melioidosis serodiagnosis. Most isolates express a conserved LPS antigen, which allows use of a single reference strain for determination of anti-LPS antibodies (). However, because some strains express different LPS antigens, serologic tests must be performed with the patient’s own strain. This case illustrates potential pitfalls in diagnosing melioidosis, which requires clinical and laboratory awareness and knowledge of its geographic distribution. LPS-based serologic assays should use a range of isolates representative of known LPS types. A) Gram stain of pus from the patient’s submental collection, showing the characteristic safety-pin pattern (arrows) of bipolar staining. B) Sodium dodecyl sulfatepolyacrylamide gel electrophoresis of lipopolysaccharide (LPS) antigens from the patient and Burkholderia pseudomallei reference strain (204), showing different O-repeating units (bracket). A control isolate of Pseudomonas aeruginosa LPS (PA01) is shown for comparison.
  8 in total

1.  Melioidosis, the mimicker of maladies.

Authors:  T Jacob John
Journal:  Indian J Med Res       Date:  2004-03       Impact factor: 2.375

2.  Development and evaluation of a real-time PCR assay targeting the type III secretion system of Burkholderia pseudomallei.

Authors:  Ryan T Novak; Mindy B Glass; Jay E Gee; Daniel Gal; Mark J Mayo; Bart J Currie; Patricia P Wilkins
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

3.  Imported melioidosis in England and Wales.

Authors:  D A Dance; M D Smith; H M Aucken; T L Pitt
Journal:  Lancet       Date:  1999-01-16       Impact factor: 79.321

4.  Melioidosis In India: the tip of the iceberg?

Authors:  T J John; M V Jesudason; M K Lalitha; A Ganesh; V Mohandas; T Cherian; D Mathai; M J Chandy
Journal:  Indian J Med Res       Date:  1996-01       Impact factor: 2.375

Review 5.  Melioidosis: the tip of the iceberg?

Authors:  D A Dance
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

6.  Homogeneity of lipopolysaccharide antigens in Pseudomonas pseudomallei.

Authors:  T L Pitt; H Aucken; D A Dance
Journal:  J Infect       Date:  1992-09       Impact factor: 6.072

7.  Septicaemic melioidosis in a tertiary care hospital in south India.

Authors:  Mary V Jesudason; Anand Anbarasu; T Jacob John
Journal:  Indian J Med Res       Date:  2003-03       Impact factor: 2.375

8.  Intensity of rainfall and severity of melioidosis, Australia.

Authors:  Bart J Currie; Susan P Jacups
Journal:  Emerg Infect Dis       Date:  2003-12       Impact factor: 6.883

  8 in total
  7 in total

1.  Genetic tools for select-agent-compliant manipulation of Burkholderia pseudomallei.

Authors:  Kyoung-Hee Choi; Takehiko Mima; Yveth Casart; Drew Rholl; Ayush Kumar; Ifor R Beacham; Herbert P Schweizer
Journal:  Appl Environ Microbiol       Date:  2007-12-21       Impact factor: 4.792

2.  BurkDiff: a real-time PCR allelic discrimination assay for Burkholderia pseudomallei and B. mallei.

Authors:  Jolene R Bowers; David M Engelthaler; Jennifer L Ginther; Talima Pearson; Sharon J Peacock; Apichai Tuanyok; David M Wagner; Bart J Currie; Paul S Keim
Journal:  PLoS One       Date:  2010-11-12       Impact factor: 3.240

Review 3.  The bacterial aetiology of adult community-acquired pneumonia in Asia: a systematic review.

Authors:  Leon Peto; Behzad Nadjm; Peter Horby; Ta Thi Dieu Ngan; Rogier van Doorn; Nguyen Van Kinh; Heiman F L Wertheim
Journal:  Trans R Soc Trop Med Hyg       Date:  2014-04-29       Impact factor: 2.184

4.  The Identification and Differentiation between Burkholderia mallei and Burkholderia pseudomallei Using One Gene Pyrosequencing.

Authors:  Damian H Gilling; Vicki Ann Luna; Cori Pflugradt
Journal:  Int Sch Res Notices       Date:  2014-10-02

5.  Multiplex qPCR for reliable detection and differentiation of Burkholderia mallei and Burkholderia pseudomallei.

Authors:  Ingmar Janse; Raditijo A Hamidjaja; Amber C A Hendriks; Bart J van Rotterdam
Journal:  BMC Infect Dis       Date:  2013-02-14       Impact factor: 3.090

Review 6.  Particle size and pathogenicity in the respiratory tract.

Authors:  Richard James Thomas
Journal:  Virulence       Date:  2013-11-13       Impact factor: 5.882

7.  Seroprevalence of Burkholderia pseudomallei among Adults in Coastal Areas in Southwestern India.

Authors:  Kalwaje Eshwara Vandana; Chiranjay Mukhopadhyay; Chaitanya Tellapragada; Asha Kamath; Meghan Tipre; Vinod Bhat; Nalini Sathiakumar
Journal:  PLoS Negl Trop Dis       Date:  2016-04-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.